Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

France

 

FREE BLOG No one is pushing lab diagnostics

Lab diagnostics remains a Cinderella sector. At approximately 2% of healthcare expenditure in most West European countries, it is too small to be of interest to the powerful sales forces and lobbyists from big pharma and big medtech.

Vedici enters Normandy

Vedici, the French private hospital group where private equity house CVC has a 60% stake, is buying the Polyclinic de la Manche at Saint-Lô and the Clinique du Parc at Caen. The properties are being bought by a French REIT. We hear there was serious competition.

Vitalia for sale (again)

Blackstone, the private equity owner of Vitalia, has yet again put the French private hospital group up for sale. What are its prospects for the group, which Healthcare Europa estimates should have sales of €700m in 2014?

Labco postpones IPO

Labco, the big Pan-West European lab group has decided to postpone its IPO until 2015. We look at why.

French lab market shrinks by 1%, as government gives up on reform

Social security reimbursements for French lab tests fell 1% in the first seven months of 2014, following a drop of 0.8% for calendar 2013. Does this mean that the government will halt its annual price cut of nearly 3%? Meanwhile, the government has retreated from radical plans, which would have seen a liberalisation of the biologiste profession which controls the lab sector in France.

Will France liberalise pathology, pharmacies and dentistry?

The French liberal professions have reacted with fury to a set of proposed reforms which would allow private capital to invest in diagnostic labs and pharmacies. Other proposals would end restricted intake, which restricts access to training for dentists and might give a wider role to non-dentists such as hygienists and technicians. The report, compiled in March 2013 by the Inspection Générale des Finances, was only published in September 2014. But does it have a hope in Hell of becoming law?

Stimulus plans European roll out

French occupational and pyschological wellbeing healthcare outfit Stimulus has plans to expand across Europe, following a management buy out backed by Turenne Sante, a specialist fund investing in the French healthcare services sector. We talk to Stimulus CEO David Mahe about his plans.

Teleradiology brightens up

After years of disappointingly slow growth, has teleradiology, the interpretation of images by radiologists sited remotely, started to turn the corner? Europe’s largest player Telemedicine Clinic (TMC) says it has seen 20-30% compound growth for the past four years. We speak to Alexander Böhmcker, TMC’s CEO, who says even Germany is showing signs of opening up.

Find Us